Tzur Yigal, Israel · Founded 2004 · Acquired/Merged (Operating Subsidiary)
Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. BioProtect is based in Tzur Yigal, Israel and was founded in 2004. Its last known valuation is $200 million (Jan 2026). It has raised $67.9 million.
Last price · $/share
—
Implied valuation
$200.0M
Total raised
$67.9M
Last round
—
Cap table — not yet on record
BioProtect's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioProtect with a free account
·The complete investor list: 21 names
·Watch BioProtect: the Monday email on marks, rounds and moves
